Zhao Jinlian, Evangelopoulos Dimitrios, Bhakta Sanjib, Gray Alexander I, Seidel Véronique
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Mycobacteria Research Laboratory, Department of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, London, UK.
J Ethnopharmacol. 2014 Aug 8;155(1):796-800. doi: 10.1016/j.jep.2014.06.034. Epub 2014 Jun 20.
Arctium lappa and Tussilago farfara (Asteraceae) are two plant species used traditionally as antitubercular remedies. The aim of this study was (i) to screen Arctium lappa and Tussilago farfara extracts for activity against Mycobacterium tuberculosis and (ii) to isolate and identify the compound(s) responsible for this reputed anti-TB effect.
The activity of extracts and isolated compounds was determined against Mycobacterium tuberculosis H37Rv using a high throughput spot culture growth inhibition (HT-SPOTi) assay.
The n-hexane extracts of both plants, the ethyl acetate extract of Tussilago farfara and the dichloromethane phase derived from the methanol extract of Arctium lappa displayed antitubercular activity (MIC 62.5 μg/mL). Further chemical investigation of Arctium lappa led to the isolation of n-nonacosane (1), taraxasterol acetate (2), taraxasterol (3), a (1:1) mixture of β sitosterol/stigmasterol (4), isololiolide (5), melitensin (6), trans-caffeic acid (7), kaempferol (8), quercetin (9), kaempferol-3-O-glucoside (10). Compounds isolated from Tussilago farfara were identified as a (1:1) mixture of β sitosterol/stigmasterol (4), trans-caffeic acid (7), kaempferol (8), quercetin (9), kaempferol-3-O-glucoside (10), loliolide (11), a (4:1) mixture of p-coumaric acid/4-hydroxybenzoic acid (12), p-coumaric acid (13). All compounds were identified following analyses of their physicochemical and spectroscopic data (MS, (1)H and (13)C-NMR) and by comparison with published data. This is the first report of the isolation of n-nonacosane (1), isololiolide (5), melitensin (6) and kaempferol-3-O-glucoside (10) from Arctium lappa, and of loliolide (11) from Tussilago farfara. Amongst the isolated compounds, the best activity was observed for p-coumaric acid (13) (MIC 31.3 μg/mL or 190.9 μM) alone and in mixture with 4-hydroxybenzoic acid (12) (MIC 62.5 μg/mL).
The above results provide for the first time some scientific evidence to support, to some extent, the ethno-medicinal use of Arctium lappa and Tussilago farfara as traditional antitubercular remedies.
牛蒡和款冬(菊科)是两种传统上用作抗结核药物的植物。本研究的目的是:(i)筛选牛蒡和款冬提取物对结核分枝杆菌的活性;(ii)分离并鉴定具有这种抗结核作用的化合物。
采用高通量斑点培养生长抑制(HT-SPOTi)试验测定提取物和分离化合物对结核分枝杆菌H37Rv的活性。
两种植物的正己烷提取物、款冬的乙酸乙酯提取物以及牛蒡甲醇提取物的二氯甲烷相均显示出抗结核活性(最低抑菌浓度为62.5μg/mL)。对牛蒡进行进一步的化学研究,分离出了正二十九烷(1)、乙酸蒲公英甾醇酯(2)、蒲公英甾醇(3)、β-谷甾醇/豆甾醇(1:1)混合物(4)、异苦艾内酯(5)、蜂斗菜素(6)、反式咖啡酸(7)、山柰酚(8)、槲皮素(9)、山柰酚-3-O-葡萄糖苷(10)。从款冬中分离出的化合物鉴定为β-谷甾醇/豆甾醇(1:1)混合物(4)、反式咖啡酸(7)、山柰酚(8)、槲皮素(9)、山柰酚-3-O-葡萄糖苷(10)、苦艾内酯(11)、对香豆酸/4-羟基苯甲酸(4:1)混合物(12)、对香豆酸(13)。所有化合物均通过对其理化和光谱数据(质谱、氢谱和碳谱核磁共振)进行分析,并与已发表数据进行比较后鉴定。这是首次从牛蒡中分离出正二十九烷(1)、异苦艾内酯(5)、蜂斗菜素(6)和山柰酚-3-O-葡萄糖苷(10),以及从款冬中分离出苦艾内酯(11)的报道。在分离出的化合物中,对香豆酸(13)单独以及与4-羟基苯甲酸(12)混合时表现出最佳活性(最低抑菌浓度分别为31.3μg/mL或190.9μM和62.5μg/mL)。
上述结果首次提供了一些科学证据,在一定程度上支持了牛蒡和款冬作为传统抗结核药物的民族药用价值。